Heather Halls - research poster presentation

Lara Motta - research poster presentation

POCT Policy and Benefits/Limitations

Shephard M. Point-of-Care Testing in Australia: The Status, Practical Advantages, and Benefits of Community Resiliency Point of Care 2013; 12: 41-45.

Shephard M, Leibie A, Dimech W, Condie D, Nolan M. Guidelines and recommendations for the quality-assured conduct of point-of-care testing for infectious diseases and drugs of abuse in Australia, Australian Journal of Medical Science 2012; 33: 143-154.

Jones GR, Barker G, Goodall I, Schneider HG, Shephard MDS, Twigg SM. Change of HbA1c reporting to SI units.   Medical Journal of Australia 2011; 195: 45-46.

Barker G, Shephard M, Goodall I, Oberstellar E, Jones G.  HbA1c – Measuring Change. Australian Doctor 2011; 18 November, 33-37.

Shephard M.  Point-of-care testing comes of age in Australia. Australian Prescriber 2010; 3: 6-9.

Gill J and Shephard MDS.  The conduct of quality control and quality assurance testing for PoCT outside the laboratory. Clinical Biochemist Reviews 2010; 31: 81-84.

Shephard M.  Analytical goals for point-of-care testing used for diabetes management in Australian health care settings outside the laboratory.   Point-of-Care: The Journal of Near-Patient Testing and Technology 2006; 5: 177-185.


POCT - Management of POCT Services

Shephard M, Halls H, McAteer B, Mazzachi M, Motta L, Spaeth B, Shephard A. Management challenges for Point-of-Care Co-ordinators in delivering training and competency programs. Point of Care 2013; 12: 84-85.

Shephard MDS.How to set up and manage a point-of-care testing service. Clinical Biochemist Newsletter 2004; 153 (June): 36-41.


POCT - University teaching

Shephard M, Halls H and Motta L.  New Postgraduate Academic Qualifications for Point-of-Care Coordinators  Point of Care 2012; 11: 173-175.


POCT - Device Evaluation

Spaeth B, Shephard A, Shephard M and Mathew T. Clinical Biochemistry entitled: Assessment of a point-of-care device for measuring creatinine in a community screening program for chronic kidney disease. Medical Research Archives 2015; 3: 1-6. Available at: http://dx.doi.org/10.18103/mra.v0i3.132

Spaeth B, Shephard M, McCormack B and Sinclair G.  Evaluation of HemoCue White Blood Cell Differential Counter at a Remote Health Centre in Australia’s Northern Territory. Pathology 2015; 47: 91-95.

Tabrizi S, Unemo M, Golparian D, Twin J, Limnios A, Lahra M, Guy R on behalf of the TTANGO Investigators. Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Journal of Clinical Microbiology 2013; 51: 1945-1947.

Shephard M.  Point-of-care testing and creatinine measurement. Clinical Biochemist Reviews 2011; 32: 109-114.

Gialamas A, Laurence C, Yelland L, Tideman P, Worley P, Shephard M et al.  Assessing agreement between point of care and laboratory results for lipid testing from a clinical perspective. Clinical Biochemistry 2010; 43: 515-518.

Shephard MD, Peake MJ, Corso O, Shephard AK, Mazzachi BC, Spaeth BA, Mathew TH.  Assessment of the Nova StatSensor whole blood point-of-care creatinine analyser for the measurement of kidney function in screening for chronic kidney disease. Clinical Chemistry and Laboratory Medicine 2010; 48: 1113-1119.

Shephard MDS, Mazzachi BC and Shephard AK.  Comparative performance of two point-of-care analysers for lipid testing.  Clinical Laboratory 2007; 53: 561-566.

Shephard M and Whiting M.  Assessment of the practicability and analytical performance of a point-of-care affinity chromatography haemoglobin A1c analyser for use in the non-laboratory setting.  Annals of Clinical Biochemistry 2006; 43; 513-515.

Martin D, Shephard M, Freeman H, Jones TW, Davis E and Maguire G.  Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.   Medical Journal of Australia 2005; 182: 524-527.

Shephard MDS and Tallis G.  Assessment of the point-of-care Cholestech Lipid Analyser for lipid screening in Aboriginal communities. Australian Journal of Medical Science 2002; 23: 4-10.

Shephard MDS, Barratt L, Simpson-Lyttle W.  Is the Bayer DCA 2000 acceptable as a screening instrument for the early detection of renal disease?   Annals of Clinical Biochemistry 1999; 36: 393-394.


POCT - Chronic Disease

Shephard M, O'Brien C, Burgoyne A, Croft J, Garlett T, Barancek K, Halls H, McAteer B, Motta L and Shephard A. A Review of the Cultural Safety of a National Indigenous Point-of-Care Testing Program for Diabetes Management. Australian Journal of Primary Health published online 2 September 2015. Available at: http://dx.doi.org/10.1071/PY15050

Dawkins RCH, Oliver GF, Sharma M, Pinto BM, Jeronimo B, Pereira B, Magno J, Motta L, Verma N, Shephard M. An estimation of the prevalence of diabetes mellitus and diabetic nephropathy in adults in Timor-Leste. BMC Research Notes 2015; 8: 249 DOI 10.11.1186/s13104-015-1171-3

Motta L, Shephard M. The international ACE Program – Point-of-care testing for diabetes management. Point of Care 2015; 14:76-80.

Motta L, Shephard M, Halls H, Barnes G and Senior J.  Optimising point-of-care testing for diabetes management in a rural Australian general practice. Point of Care 2015; 14:25-31.

Shephard A, Shephard M, Halls H, Corso O, Mathew T.  Innovative use of point-of-care testing for chronic kidney disease screening.   Point of Care 2011; 10: 98-101.

Shephard MDS and Gill J.  The national QAAMS Program – A practical example of PoCT working in the community. Clinical Biochemist Reviews 2010; 31: 95-99.

Mathew T, Corso O, Ludlow M, Boyle A, Cass A, Chadban S, Joyner B, Shephard M, Usherwood T.  Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney International 2010; 77 (Supp 116): S9-S16.

Shephard M, Allen G, Paizis K, Barbara J, Batterham M and Vanajek A. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio. Rural and Remote Health 2006; 6: Article 591

Shephard MDS and Gill JP.  The analytical quality of point-of-care testing in the ‘QAAMS’ model for diabetes management in Australian Aboriginal medical services.  Clinical Biochemist Reviews 2006; 27:185-190.

Shephard M.  Clinical and cultural effectiveness of the ‘QAAMS’ point-of-care testing model for diabetes management in Australian Aboriginal medical services.   Clinical Biochemist Reviews 2006; 27: 161-170.

Shephard M, Mazzachi B, Shephard A, Burgoyne T, Dufek A, Ahkit J, Mills D and Dunn D.  Point-of-care testing in Aboriginal hands – a model for chronic disease prevention and management in Indigenous Australia.   Point-of-Care: The Journal of Near-Patient Testing and Technology 2006; 5: 168-176.

Shephard MDS and Gill JP.  An innovative Australian point-of-care model for urine albumin:creatinine ratio testing that supports diabetes management in indigenous medical services and has international application.   Annals of Clinical Biochemistry 2005; 42:208-215.

Shephard M, Mazzachi B, Shephard A, McLaughlin K, Barnes G and Denner B. The impact of point of care testing on diabetes services along Victoria’s Mallee Track. Results of a community-based diabetes risk assessment and management program. Rural and Remote Health 5:371.

Shephard MDS.  Point-of-care testing in the Indigenous Rural Environment – the Australasian Experience.  Chapter 29 p 293-301. In: Point-of-Care Testing. Price C, Hicks J and St John A (eds). AACC (American Association of Clinical Chemistry) Press, Washington DC, July 2004.

Shephard MDS.  Point-of-care testing in the Indigenous Rural Community.  Clinical Biochemist Newsletter 2004; 153 (June): 26-31.

Shephard MDS and Gill J.  Results of an Innovative Education, Training and Quality Assurance Program for Point-of-Care HbA1c Testing using the Bayer DCA 2000 in Australian Aboriginal Community Controlled Health Services.  Clinical Biochemist Reviews 2003; 24: 123-131.

Shephard MDS and Mundraby K.  Assisting diabetes management through point-of-care HbA1c testing – the ‘QAAMS’ program for Aboriginal health workers.  Aboriginal and Islander Health Worker Journal 2003; 27 (4): 12-18.

Shephard MDS, Allen GG, Barratt LJ, Paizis K, Brown M, Barbara JAJ, McLeod G, Vanajek A. Albuminuria in a remote South Australian Aboriginal community: results of a community-based screening program for renal disease. Rural and Remote Health 2003; 3 (online) 8 February 2003.

Shephard M.  Point-of-care testing in the Aboriginal community.  Australian Journal of Medical Science 2003; 24: 10-16.

Jones R, Mazzachi B, Shephard M.  Point-of-Care in Aboriginal Hands. Aboriginal and Islander Health Worker Journal 2002; 26 (6): 13-16.

Zeunert S, Cerro N, Boesch L, Duff M, Shephard MDS, Jureidini KF and Braun J.  Nutrition project in a remote Australian Aboriginal community.  Journal of Renal Nutrition 2002; 12: 102-106.

Shephard MDS and Allen GG.   Screening for renal disease in a remote Aboriginal community using the Bayer DCA 2000.   Australian Journal of Medical Science 2001; 22: 164-170.

Shephard MDS, Brown M, Hudson M, Riessen C and Braun J.  The Umoona Kidney Project.   Aboriginal and Islander Health Worker Journal 2000; 24 (2): 12-15.


POCT - Acute Care

Shephard M, Spaeth B, Auld M, Schatz M, Lingwood A, Loudon J, Rigby J, Daniel V. Towards sustainable point-of-care testing in remote Australia – the Northern Territory i-STAT Point-of-Care Testing Program. Point of Care 2014; 13; 6-11.

Shephard M, Spaeth B, Mazzachi B, Auld M, Schatz S, Loudon J, Rigby J, Daniel V.  Design, implementation and initial assessment of the Northern Territory Point-of-Care Testing Program. Australian Journal of Rural Health 2012; 2012: 16-21.


POCT - Infectious Disease

Causer L, Hengel B, Natoli L, Tangey A, Badman S, Tabrizi S, Whiley D, Ward J, Kaldor J, Guy R on behalf of TTANGO investigators. Field evaluation of three point-of-care tests for chlamydia and gonorrhoea in remote health services in Australia. Sexual Health 2015; 12: 27-33.

Natoli L, Guy RJ, Shephard M, Donovan B, Fairley C, Ward J, Regan D, Hengel B, Maher L on behalf of the TTANGO Investigators. Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used? Sexual Health 2015; http://dx.doi.org/10.1071/SH14213 (on-line 23 February 2015).

Natoli L, Guy RJ, Shephard M, Whiley D, Tabrizi SN, Ward J, Regan DG, Badman SG, Anderson DA, Kaldor J, Maher L on behalf of the TTANGO investigator group. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. BMJOpen 2015;5:e006922.doi:10.1136/bmjopen-2014-006922.

Motta, L, Shephard M and Keen P. A review of the use of rapid HIV testing in community settings, with specific reference to Australia ,Point of Care 2013; 12: 27-32.

Guy R, Natoli l, Ward J, Causer L, Hengel B, Whiley D, Tabrizi S, Donovan B, Fairley C, Badman S, Tangey A, Wand H, Shephard M, Regan D, Wilson D, Anderson D, Kaldor J. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO - the ‘TTANGO’ trial protocol. BMC Infectious Diseases 2013; 13: 485. Available at http://www.biomedcentral.com/1471-2334/13/485

Ward J, Natoli L, Causer L, Kaldor J, Guy R on behalf of the TTANGO Investigators. What is the role of HIV and STI point-of-care tests in remote Aboriginal and Torres Strait Islander communities? HIV Australia 2013; 11: 51-54.


POCT - Aged Care

Khalil H, Halls H, Chambers H, Walker J, Shephard MDS. Managing chronic diseases in rural aged care facilities using point-of-care systems. Rural and Remote Health 13; 2597. (Online) 2013.


POCT - General Practice

Shephard M.  The influence of geography on the performance of quality control testing in the Australian Government’s Point of Care Testing in General Practice Trial. Clinical Biochemistry 2009; 42: 1325-1327. 

Shephard M, Shephard A, Watkinson L, Mazzachi B and Worley P.  Design, implementation and results of the Quality Control program for the Australian Government’s Point of Care Testing in General Practice Trial.  Annals of Clinical Biochemistry 2009; 46: 413–419.

Shephard M, Mazzachi B, Watkinson L, Shephard A, Laurence A, Gialamas A and Bubner T. Evaluation of a training program for device operators in the Australian Government’s Point of Care Testing In General Practice Trial. Rural and Remote Health 2009; 9: 1189.

Laurence C, Gialamas A, Yelland L, Bubner T, Ryan P, Willson K, Glastonbury B, Gill J, Shephard M, Beilby J.  A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting – rationale, design and baseline characteristics.  Trials 2008; 9:50

Shephard M.  Point-of-Care Testing Trial in General Practice in Australia.   Point-of-Care: The Journal of Near-Patient Testing and Technology 2006; 5: 192.